GE Healthcare’s AIR Recon DL Receives FDA Clearance of 3D and Motion-Insensitive Imaging Applications for Next-Level Image Quality and Patient Experience in MRI

Extending deep learning-based AIR Recon DL compatibility to 3D & PROPELLER has the potential to enable more confident patient diagnoses in MRI Chicago, US, September 29, 2022 – GE Healthcare announced US FDA 510(k) clearance of its breakthrough AIR Recon DL for 3D and PROPELLER imaging sequences[1]. The benefits of AIR Recon DL are extended... Read more

Danaher Schedules Third Quarter 2022 Earnings Conference Call

WASHINGTON, Sept. 20, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2022 on Thursday, October 20, 2022 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of... Read more

Annual Report 2022

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more

Consolidated Financial Results for the Three Months Ended June 30, 2022 (Under Japanese GAAP)

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more

Bruker Reports Second Quarter 2022 Financial Results

Q2 2022 reported revenue growth of 3.1% year-over-year (yoy); organic revenue growth of 8.8% Q2 2022 GAAP EPS $0.33; non-GAAP EPS $0.45, up 2.3% yoy Maintaining FY 2022 guidance for high, single-digit organic revenue growth, non-GAAP operating profit margin expansion and non-GAAP EPS increase BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced financial results... Read more

Eppendorf opens new site in Singapore

New subsidiary at the center of the Asian life science growth markets Targeted strengthening of customer focus with high-tech laboratory for pipette calibration and extensive range of high-quality laboratory services Even faster and more reliable delivery thanks to new central warehouse Singapore/Hamburg, August 1, 2022 – The globally active Eppendorf Group continues its growth track... Read more